🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The administration of first-line pembrolizumab monotherapy or combined chem...
Status
Active Not Recruiting
Location
West China Hospital, Sichuan University
Start Date
2024-08-01
Trial ID
NCT06508606
Treatments Being Tested
This is a phase 3 study. All subjects arerecurrent or metastatic head and n...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2024-10-30
Trial ID
NCT06601335
Treatments Being Tested
This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter...
Status
Recruiting
Location
UCLA Ronald Reagan Medical Center
Start Date
2024-02-07
Trial ID
NCT06196203
Treatments Being Tested
Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2022-01-22
Trial ID
NCT05214482
Treatments Being Tested
This is a phase 1b/2 study. All patients are diagnosed with Acute Myeloid L...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2024-04-29
Trial ID
NCT06387420
Treatments Being Tested
This trial is a Phase II study. The purpose of this study is to evaluate th...
Status
Active Not Recruiting
Location
Summit Therapeutics Research Site
Start Date
2022-06-27
Trial ID
NCT05382442
Treatments Being Tested
This is a randomized, open-label, active-comparator-controlled, multi-regio...
Status
Recruiting
Location
Centre Guillaume Le Conquerant
Start Date
2026-05-05
Trial ID
NCT07264075
Treatments Being Tested
This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-06-11
Trial ID
NCT06953999
Phase Ib/II open label, multicenter study to evaluate the efficacy and safe...
Status
Completed
Location
Shanghai Renji Hospital
Start Date
2022-03-12
Trial ID
NCT05235542
Treatments Being Tested